Business

U.S. stocks mixed early; bond prices tumble

Utilities were down the most, sliding 3.7 percent, followed by consumer-focused stocks, down 1.3 percent. The S&P 500 index was 0.14 percent down. Natural gas rose 6 cents, or 2.2 percent, to $2.69 per 1,000 cubic feet. The Canadian dollar was down 0.82 of a USA cent, trading at 74.34 cents United States as North American stock markets opened. Mr Trump's victory has raised concerns that the U.S.

Business

SBI Q2 profit plunges 99.6 per cent on higher bad loan provisioning

Total Income has increased from Rs 9,044 crore for the quarter ended September 30, 2015 to Rs 10,337 crore for the quarter ended September 30, 2016. Its profit stood at Rs 4,991.70 crore in the same quarter last fiscal. We have also internally taken the decision about not really increasing our exposure to those areas where peripheral business is not there. The BSE group "A" stock of face value Rs 1 has touched a 52 week high of Rs 358.55 on 02-Aug-2016 and a 52 week low of Rs 206.2 on ...

Business

Mexican stocks, peso take a beating following Trump victory

LONDON, Nov 10 The dollar jumped to its highest level in two weeks and continued to reverse brief initial losses from the surprise election of businessman Donald Trump as US president, as markets awaited more clarity on his economic policy.

Business

Fort Trump: New security measures ring Trump Tower

The Trump Tower has always been a draw for crowds of shoppers and tourists, but now it's different. Formal concrete blockades and steel barricades have replaced the cement and sanitation trucks that were used by the NYPD for a temporary barricade.

Business

India, Japan sign landmark civil nuclear deal

Reports suggest that the deal between India and Japan would be concluded along the lines of the NPT, and Tokyo would walk out of the deal of India carries out a nuclear test, which it is highly unlikely to do considering its past record.

Business

Tax gain and cost cuts help AstraZeneca offset flagging Crestor

The Anglo-Swiss firm said total revenues dropped 4% to 5.7 billion USA dollars (£4.6 billion) in the three months to September 30, as its top-selling drug took a hit from the launch of a number of Crestor generic medicines. That promise was a key part of his defense against an unsolicited, and ultimately failed, takeover bid by Pfizer in 2014. Soriot said strong trajectory in growth should begin during the second quarter of 2017.